Table 4-16 - Use of Mood Stabilizing Medications For Bipolar

Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

Essentials of Psychiatry in Primary Care: Behavioral Health in the Medical Setting >Major Depression and

Related Disorders
Robert C. Smith, Gerald G. Osborn, Francesca C. Dwamena, Dale D'Mello, Laura Freilich, Heather S. Laird-Fick+
Table 4-16.Use of Mood Stabilizing Medications for Bipolar Disorders

Indications Starting Dose (mg/d) Titration Target Dose Side Effects Comment

Stevens-Johnson
syndrome

Lamotrigine 25/d × 2 wk; then 50/d × 2


Depression “Rash” Instruct patients to report
25 daily wk; then 100/d × 2 wk, 200-300 per day
any rash immediately
Lamictal then 200/d
Maintenance Hepatitis

Anemia, leukopenia,
thrombocytopenia

Encephalopathy

Increased ammonia
Obtain at baseline and
Divalproex sodium Reaches steady state in 5
Mania/hypomania Serum valproic acid level every 3 mo: valproic acid
500-1000 twice daily d; can increase 500- Thrombocytopenia
of 85-125 µg/mL level, liver functions, and
Depakote 1000/d as tolerated
Maintenance CBC
Hepatitis, pancreatitis

Sedation, weight gain,


tremor

Stevens-Johnson
syndrome

Obtain at baseline and


Reaches steady state in Hyponatremia
Carbamazepine every 3 months:
Mania/hypomania 3-4 d; increase by 200/d
200 ER twice daily carbamazepine level,
Maintenance as tolerated; maximum = Hepatitis
Tegretol serum sodium, liver
1600/d
functions, and CBC
Pancytopenia

Vertigo, somnolence

Date of download: 12/26/22 from AccessMedicine: accessmedicine.mhmedical.com, Copyright © McGraw Hill. All rights reserved.

You might also like